Loading
AL
Aceso Life Science Group Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$1.2B
No insider purchase over the last 90 days. The latest, by FOK CHI TAK, was filed 02 Oct 2019.
Aceso Life Science Group Ltd.: what insiders have been doing
Aceso Life Science Group Ltd., founded in 2006, is a listed company. Its directors and officers file their transactions with HKEX. Aceso Life Science Group Ltd. has had no insider filing for more than a year; the last one goes back to 10 March 2020.
Our records for Aceso Life Science Group Ltd. go back to 2017, with 9 purchases and no sales on the open market in total.
In the same market, recent insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. also feature in our signals. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Key facts
Founded: 2006
Source: Wikidata (CC0).
Insider Decl.
18
Thresholds
n/a
Buy Volume
n/a
9 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
HK$0.14
Analyst consensus
Income statement
RevenueHK$58M
Gross profitHK$90M155% margin
EBITDA-HK$297M-512% margin
Net incomeHK$338M582.8% margin
Valuation
P/Book2.7x
Beta-0.30
Balance sheet & cash
Market capHK$1.2B
Total debtHK$1.2B
Free Cash FlowHK$20M
Debt / Equity266%
Profitability & ownership
ROE-71.6%
ROA-17.1%
% insiders72.9%
% institutions0.0%
Last declaration on 10 March 2020
Declarations18 total
400,000,000 shares@ HK$0.2556.0% of flowShareXHKGHKEX:DA20200310E00349
7,087,890 sharesShareXHKGHKEX:DA20191002E00458
Canonical exit: 25 Dec 2019 (T+90)
14,175,779 sharesShareXHKGHKEX:DA20190329E00305
Canonical exit: 24 Jun 2019 (T+90)
372,585,332 shares@ HK$0.216844.0% of flowShareXHKGHKEX:DA20190218E00334
382,585,332 shares@ HK$0.2168100.0% of flowShareXHKGHKEX:DA20190218E00341
14,175,779 sharesShareXHKGHKEX:DA20180329E00147
Canonical exit: 26 Jun 2018 (T+90)
104,821 shares0ShareXHKGHKEX:DA20170725E00066
3,633,100 shares0ShareXHKGHKEX:DA20170725E00064
104,821 shares0ShareXHKGHKEX:DA20170725E00068
104,821 shares0ShareXHKGHKEX:DA20170725E00070
104,821 shares0ShareXHKGHKEX:DA20170725E00071
104,821 shares0ShareXHKGHKEX:DA20170725E00072
104,821 sharesShareXHKGHKEX:DA20170713E00022
Canonical exit: 9 Oct 2017 (T+90)
3,633,100 sharesShareXHKGHKEX:DA20170713E00016
Canonical exit: 9 Oct 2017 (T+90)
104,821 sharesShareXHKGHKEX:DA20170713E00027
Canonical exit: 9 Oct 2017 (T+90)
104,821 sharesShareXHKGHKEX:DA20170713E00029
Canonical exit: 9 Oct 2017 (T+90)
104,821 sharesShareXHKGHKEX:DA20170713E00030
Canonical exit: 9 Oct 2017 (T+90)
104,821 sharesShareXHKGHKEX:DA20170713E00031
Canonical exit: 9 Oct 2017 (T+90)
18 of 18 declarations
About Aceso Life Science Group Ltd.
Aceso Life Science Group Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the life sciences sector. It focuses on the development and commercialization of innovative solutions to enhance health and well-being.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations